Medication info
Mega Acetodol Tablet

Mega Acetodol Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202002678 · Approved 2020.04.16 · Insurance code 060500320

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30mL/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10mL/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this drug after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Pediatric patients aged 12 years and older: The recommended initial dose is 2 tablets. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30mL/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10mL/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this drug after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Pediatric patients aged 12 years and older: The recommended initial dose is 2 tablets. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day.

Precautions

This medication should be discussed with a doctor or pharmacist before use in individuals who regularly consume more than three glasses of alcohol daily, as it may cause liver damage when taken with alcohol. If any adverse reactions such as rash or itching occur during treatment, discontinue use immediately and consult a doctor, as there is a risk of serious skin disorders occurring. The ingredients in this medication may increase the risk of seizures, therefore caution is needed for patients with a history of seizures or those at risk. The risk of seizures may also increase when combined with certain antidepressants or other narcotic analgesics. When administering this medication to patients with acute bronchial asthma, there is a risk of respiratory suppression, which can be life-threatening; therefore, it should only be administered in a medical facility equipped for such treatments. This medication may cause severe sedation, respiratory suppression, or coma when taken with central nervous system depressants or alcohol, so concurrent use should be avoided or done with extreme caution. Patients with head trauma or brain disorders should be cautious when taking this medication due to the risk of increased intracranial pressure and respiratory suppression. This medication may lead to physical and psychological dependence, so long-term use should be closely monitored for signs of dependency. Patients with impaired liver function should consult a doctor before taking this medication and should not exceed the recommended dosage due to the risk of liver toxicity. Particularly, patients who are ultra-rapid metabolizers of CYP2D6 may have increased levels of the active ingredient, raising the risk of respiratory suppression; hence, dosage adjustments and monitoring are necessary. This medication should not be administered to children under 12 years old or to those under 18 years who have undergone tonsillectomy or adenoidectomy. Children with sleep apnea should also avoid usage. This medication can cause sleep apnea and hypoxia, so continuous monitoring for these symptoms or any worsening is essential, with dosage adjustments or discontinuation if needed. Patients at risk of hyponatremia are advised to monitor their serum sodium levels during treatment. This medication should not be used in individuals with hypersensitivity to specific components, central nervous system drug toxicity, severe respiratory suppression, head injury, or those taking MAO inhibitors. Sudden discontinuation of this medication can cause withdrawal symptoms, so dosage should be gradually reduced under a doctor's guidance. Caution is advised when driving or operating machinery, as drowsiness or dizziness may occur, and these symptoms may worsen when taken with alcohol or other central nervous system depressants. In case of overdose, serious side effects such as respiratory suppression, seizures, or liver damage may occur; therefore, contact a medical institution immediately for appropriate treatment. This medication should be stored out of reach of children and should not be taken with other acetaminophen products to reduce the risk of liver damage.

Side effects

  • Liver damage
  • acute generalized pustular eruption
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • seizures
  • anaphylactic reactions
  • respiratory depression
  • deep sedation
  • coma
  • hepatotoxicity
Show 223 more
  • hyponatremia
  • decreased appetite
  • insomnia
  • depression
  • dizziness
  • headache
  • drowsiness
  • nausea
  • vomiting
  • constipation
  • dry mouth
  • diarrhea
  • dyspepsia
  • abdominal pain
  • abdominal discomfort
  • flatulence
  • pruritus
  • sweating
  • rash
  • fatigue
  • flushing
  • urticaria
  • hypersensitivity
  • hypoglycemia
  • anxiety
  • nervousness
  • emotional instability
  • euphoria
  • decreased libido
  • sleep disturbances
  • confusion
  • disorientation
  • agitation
  • abnormal dreams
  • drug abuse
  • hallucinations
  • withdrawal syndrome
  • migraine
  • somnolence
  • sensory loss
  • tremor
  • paresthesia
  • attention deficit
  • syncope
  • memory impairment
  • psychomotor agitation
  • sedation
  • amnesia
  • perceptual disturbances
  • convulsions
  • visual disturbances
  • visual impairment
  • pupil constriction
  • dizziness
  • tinnitus
  • ear discomfort
  • palpitation
  • tachycardia
  • hypertension
  • hypotension
  • dyspnea
  • dry throat
  • increased liver enzymes
  • generalized pruritus
  • sweating
  • urinary disturbances
  • erectile dysfunction
  • weakness
  • chest pain
  • emotional disturbance
  • chills
  • chest discomfort
  • lethargy
  • thirst
  • irritability
  • heat sensation
  • weight loss
  • increased serum creatinine
  • anaphylactic reaction
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • emotional instability
  • delirium
  • suicidal thoughts
  • muscle rigidity
  • movement disorders
  • serotonin syndrome
  • speech impairment
  • mydriasis
  • orthostatic hypotension
  • hepatitis
  • gait disturbances
  • prolonged prothrombin time
  • fixed rash
  • weakness
  • fever
  • edema
  • rigidity
  • syncope
  • congestive heart failure
  • dizziness
  • confusion
  • exacerbation of migraine
  • involuntary muscle contractions
  • exertional dyspnea
  • cough
  • bronchitis
  • urinary retention
  • frequent urination
  • abnormal kidney function tests
  • oliguria
  • increased sweating
  • dysphagia
  • tongue swelling
  • increased salivation
  • progression of rectal cancer
  • progression of esophageal cancer
  • progression of gastric cancer
  • paralytic ileus
  • hiccups
  • cholecystitis
  • drowsiness
  • insomnia
  • decreased appetite
  • anxiety
  • depression
  • nervousness
  • emotional instability
  • hallucinations
  • depersonalization
  • anemia
  • decreased hemoglobin
  • decreased red blood cells
  • increased white blood cells
  • decreased white blood cells
  • increased white blood cell count
  • decreased platelets
  • palpitations
  • exacerbation of hypertension
  • arrhythmia
  • aortic stenosis
  • gastrointestinal bleeding
  • cholesterol elevation
  • tinnitus
  • chills
  • hip pain
  • thigh pain
  • allergic rhinitis
  • nasal bleeding
  • abnormal visual field
  • progression of bile duct cancer
  • foreign body sensation in the eye
  • progression of liver cancer
  • liver dysfunction
  • nausea
  • dizziness
  • dyspnea
  • confusion
  • migraine
  • speech impairment
  • loss of consciousness
  • recurrence of myocardial infarction
  • hypotension
  • vomiting
  • dyspepsia
  • confusion
  • multiple organ failure
  • anaphylaxis
  • intentional overdose
  • belching
  • chest discomfort
  • anxiety
  • sweating
  • rigidity
  • pain
  • diarrhea
  • upper respiratory tract syndrome
  • mouth twitching
  • agitation
  • hyperactivity
  • gastrointestinal symptoms
  • panic attacks
  • severe anxiety
  • hallucinations
  • perceptual disturbances
  • tinnitus
  • abnormal central nervous system response
  • urticaria
  • rash
  • bronchospasm
  • toxic skin necrosis
  • allergic reaction
  • convulsions
  • serotonin syndrome
  • serotonin syndrome
  • respiratory arrest
  • QT prolongation
  • somnolence
  • coma
  • cardiac arrest
  • death
  • liver failure
  • renal tubular necrosis
  • coagulation disorders
  • abdominal discomfort
  • nausea
  • lethargy
  • pallor
  • increased sweating
  • withdrawal symptoms
  • anxiety
  • sweating
  • insomnia
  • rigidity
  • pain
  • nausea
  • tremors
  • diarrhea
  • upper respiratory tract syndrome
  • mouth twitching
  • agitation
  • nervousness
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature should be kept between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.